Self-Assessment 2 of 2: Myelodysplastic Syndrome (MDS)
This course is designed to provide healthcare professionals with a comprehensive understanding of anemia in the context of myelodysplastic syndrome (MDS) and equip them with the knowledge and skills necessary for effective management.
Incorporate the evidence-based data and expert recommendations regarding the initiation of treatments for anemia due to MDS.
Employ expert guidance in the management of adverse events related to luspatercept in patients with low-risk MDS.
Optimally titrate luspatercept to help ensure treatment success.
Apply knowledge of emerging treatments to management decisions in patients with MDS.